FOXO1 and type 2 diabetes mellitus: In T2D mice, the acetylation of FoxO1 was markedly reduced compared to non-diabetic CH mice (1.00±0.07 vs. 1.48±0.08 of CH mice, p<0.05, n = 5–8).